Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

新生儿肺动脉高压诊治专家共识

2017-03-30 中华医学会儿科学分会新生儿学组 中华儿科杂志.2017,55(3):163-168.

肺动脉高压新生儿

自2002年发表“新生儿持续肺动脉高压诊疗常规(草案)”以来，该病的诊治已有较大的进展；为进一步规范诊治，参考国内外相关文献和指南，中华医学会儿科学分会新生儿学组和《中华儿科杂志》编辑委员会组织相关专家共同制定了本共识。

中文标题：

新生儿肺动脉高压诊治专家共识

发布机构：

中华医学会儿科学分会新生儿学组

发布日期：

2017-03-30

简要介绍：

自2002年发表“新生儿持续肺动脉高压诊疗常规(草案)”以来，该病的诊治已有较大的进展；为进一步规范诊治，参考国内外相关文献和指南，中华医学会儿科学分会新生儿学组和《中华儿科杂志》编辑委员会组织相关专家共同制定了本共识。

 

拓展指南：与新生儿相关指南：

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=235096, encodeId=c8142350966b, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Aug 19 12:46:45 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=235049, encodeId=fc1e23504976, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Aug 19 09:57:09 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234336, encodeId=be19234336bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Aug 17 08:15:45 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233789, encodeId=6afe233e89b2, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Aug 15 10:23:43 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
    2017-08-19 ren1mw

    学习一下！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=235096, encodeId=c8142350966b, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Aug 19 12:46:45 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=235049, encodeId=fc1e23504976, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Aug 19 09:57:09 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234336, encodeId=be19234336bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Aug 17 08:15:45 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233789, encodeId=6afe233e89b2, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Aug 15 10:23:43 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
    2017-08-19 suibian2007bbb

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=235096, encodeId=c8142350966b, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Aug 19 12:46:45 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=235049, encodeId=fc1e23504976, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Aug 19 09:57:09 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234336, encodeId=be19234336bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Aug 17 08:15:45 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233789, encodeId=6afe233e89b2, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Aug 15 10:23:43 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
    2017-08-17 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=235096, encodeId=c8142350966b, content=学习一下！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Aug 19 12:46:45 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=235049, encodeId=fc1e23504976, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4KDsF1g1gUHzGM0LHxX5B5uhEMln8y8iagso9N4XBTQVPmHrCNoT3o8bw80Ds53TpTgcPnKUIfkyw/0, createdBy=bc101976400, createdName=suibian2007bbb, createdTime=Sat Aug 19 09:57:09 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234336, encodeId=be19234336bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Aug 17 08:15:45 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233789, encodeId=6afe233e89b2, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Aug 15 10:23:43 CST 2017, time=2017-08-15, status=1, ipAttribution=)]
    2017-08-15 Y—xianghai

    学习了新知识

    0

相关指南

2015 ESC/ERS指南：肺动脉高压的诊断与治疗

欧洲心脏病学会(ESC,European Society of Cardiology) · 2015-08-29

2015 AHA/ATS指南：小儿肺动脉高压

美国心脏协会(AHA,American Heart Association) · 2015-11-03

2015 ESC/ERS肺动脉高压诊断和治疗指南

欧洲心脏病学会(ESC,European Society of Cardiology) · 2015-08-30

2015年先天性心脏病相关性肺动脉高压诊治中国专家共识

中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians) · 2015-02-20

中国成人系统性红斑狼疮相关肺动脉高压诊治共识

中国系统性红斑狼疮研究协作组(CSTAR,Chinese SLE Treatment And Research Group) · 2015-02-01

2014 ACCP成人肺动脉高压药物治疗指南

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2014-06-17

Baidu
map
Baidu
map
Baidu
map